Insights
Trending Now
AI is quietly reshaping drug discovery, improving early-stage efficiency and influencing how biotech innovators and pharmaceutical leaders approach pipeline development and long-term growth.
CEO Jan van Eck’s 2026 outlook highlights where visibility is improving. Here we show how we express those views in portfolios.
Trending Funds
_ of _